As the year draws to a close, ReBlood Rx continues to advance on multiple fronts.
November has been a month centered on strengthening partnerships, refining
operations, and aligning our efforts for a strong start to the new year. With steady
progress across our technical and business milestones, we’re grateful for the
continued support of our network as we move toward the next phase of growth.
Building Strategic Partnerships!
Our focus this month has been on developing commercial partnerships and
strengthening vendor relationships to ensure we’re positioned for long-term
scalability. These collaborations are key as we work toward delivering initial product
samples in early 2026 for review by our strategic collaborators. Every step brings us
closer to translating our technology into real-world impact for animals and humans.
Grant Updates!
We are eagerly awaiting a decision this month on the NATO DIANA grant, which
represents an incredible opportunity to expand our reach and accelerate innovation.
Advancing through this competitive process has been a testament to the strength of
our mission and team, and we’re optimistic about what’s ahead.
Achievements
- We’ve met with a variety of organizations exploring new and meaningful ways ReBlood Rx can use our technology for good, expanding the scope of our impact across animal and human health.
- We’re continuing to fine-tune our manufacturing capabilities, integrating newequipment to enhance consistency and scalability as we prepare for upcoming milestones.
- Thank you to all who keep up with our journey on LinkedIn! If you are not following our page, visit us here to stay up to date!
Opportunities
- If you or someone you know is willing to share your experiences with HBOC use in the Veterinarian Industry, we would love to hear your thoughts.
- Now that we are pitching to potential investors, if you would like to review our deck or listen to our pitch and provide us with constructive feedback, please let us know!
- ReBlood Rx is eager to learn and grow! If you know of any accelerator opportunities, we would love to hear about them.
- ReBlood Rx is looking for help sourcing grants in the DoD, NSF, or NHLBI ecosystem. If you know of any please forward them over!
Thank you all for your continued support!